![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 20, 2017 6:58:13 PM
STOCKHOLDERS’ EQUITY The Company is authorized to issue 7,500,000,000 shares of common stock and 100,000,000 shares of preferred stock as of the balance sheet date. 5,736,915,257 common shares and 80,000,000 preferred shares are issued and outstanding as of the balance sheet date. The preferred shares that were issued during the year ended December 31, 2015 have been designated as Series A Convertible Preferred Stock. Each Series A share can be converted into 1 share of common stock and has voting rights equal to 100 votes per share. They also have preferred liquidation rights equal to $0.001 per share before common shareholders. The Company also designated 10,000,000 preferred shares as Series B Convertible Preferred Stock. Each Series B share can be converted into 100 shares of common stock, but has no voting rights. They also have preferred liquidation rights equal to $1.00 per share before common shareholders. No Series B shares have been issued as of the balance sheet date.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM